Last reviewed · How we verify
NCT05343949
High Intensity Interval Training and Technologies in COPD
NA trial testing HIIT exercise program ABC in COPD in 18 participants. Terminated before completion.
25 November 2022
Quick facts
| Lead sponsor | Hull University Teaching Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 18 |
| Start date | 8 May 2019 |
| Primary completion | 25 November 2022 |
| Estimated completion | 25 November 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- HIIT exercise program ABC
- HIIT exercise program CAB
- HIIT exercise program BCA
Conditions studied
- COPD — all drugs for COPD →
Sponsor
Hull University Teaching Hospitals NHS Trust
Who can join
Adults 30 to 90, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Trials in COPD have shown that HIIT leads to the same positive outcomes as constant load training but causes less breathlessness and leg discomfort during training. However, HIIT protocols in existing trials have all been different and use relatively long interval durations (30 s) and short rests. This is sub-optimal because long interval durations lead to greater breathlessness and patients may fear that they will not fully recover during short rests, potentially decreasing adherence. A novel HIIT protocol involving very brief intervals (e.g. 10 s) with longer rests may provide the same benefits with less distress due to breathlessness.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05343949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COPD
Currently open trials in the same condition.
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
Other Hull University Teaching Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT07502040 — Impact of Exercise Access on Physio Outcomes Post Knee Replacement · NA · not yet recruiting
- NCT07483502 — The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Sur · NA · not yet recruiting
- NCT07427550 — Palliative Care and The Terminally Ill Adults (End of Life) Bill · not yet recruiting
- NCT06876506 — Identification of B Regulatory Cells by Flow Cytometry · not yet recruiting
- NCT07409519 — Nutritional Screening in Cardiovascular Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05343949 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hull University Teaching Hospitals NHS Trust
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05343949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing